Targeting Neurotransmitters for the Management of Insomnia– Insomnia can affect many aspects of an individual’s life: impairing concentration and memory, increasing the risk of incident depression or recurrence of a depressive episode, diminishing a patient’s ability to enjoy family and social relationships, and increasing the risks of falls and motor vehicle accidents.
This neuroscienceCME Clinical Navigator will describe the treatments used in insomnia, so that clinicians understand more about the roles of neurotransmitters and therapeutic agents, including orexin antagonists. It is important for clinicians to be aware of emerging agents in order to tailor treatments to individual needs as new therapeutic options for insomnia become available.
Evaluate how research findings for emerging agents will likely affect routine clinical practice in the care of patients with insomnia.
1.0 Free CEUs for Sleep Technologists
This course also offers Free CME for Physicians